cGxP.wire https://validator.w3.org/feed/docs/rss2.html Oncolytics Biotech Wins FDA Fast Track for Pelareorep Telix Doses First Patient in Phase 3 LUTEON Trial of TLX250-Tx Kinaset Doses First Patient in Phase 2b Frevecitinib Trial Belite Bio Reports Positive Phase 3 Tinlarebant Data at ASRS 2026 Adaptix Partners with Spartan Medical for U.S. Expansion VERAXA Achieves Key Regulatory Milestone for BiTAC-TCE Dyne Therapeutics Advances DMD Program with FDA Acceptance Immunome Doses First Patient in Phase 1 IM-3050 Radioligand Therapy Trial Marengo Reports Phase II Breast Cancer Trial Success Bristol Myers Squibb Expands AI Collaboration with NVIDIA Samsung Biologics to Acquire PolyPeptide for CHF 1.46B Can-Fite Phase 2a Namodenoson Pancreatic Cancer Data Accepted at ESMO 2026 SystImmune Advances Oncology Portfolio with Iza-bren Approval REGENXBIO Reports Positive Long-Term Gene Therapy Results Harrow Highlights New IHEEZO and BYOOVIZ Clinical Evidence at ASRS 2026 GSK Seeks EMA Approval for Bexsero Booster Vaccine Update OKYO Pharma Boosts Cash to Advance Phase 3 Urcosimod Trial BioLineRx to Present GLIX1 Ovarian Cancer Data at ESMO 2026 INmune Bio Reaches Commercial CORDStrom Manufacturing Milestone Armata Advances AP-SA02 Toward Phase III Bacteremia Trial Kamada Strengthens Plasma Supply Business with $50M Deal Almirall Seeks EMA Approval to Expand Ebglyss Use in Kids Galderma Launches Alastin in Japan and Asia Pacific to Expand Regenerative Skincare Portfolio Marengo Earns ESMO Oral Slot for Phase II Cancer Data Biohaven Unveils Promising BHV-1530 Cancer Data at ESMO Halozyme and Incyte Join Forces to Improve Cancer Drug Delivery SNIS 2026 Unveils AI Breakthrough in Brain Tumor Treatment Nuvation Bio Expands Safusidenib Program with Strong Phase II Data Consano Bio Wins FDA IND Clearance for C-1101 Therapy APhA Urges FDA to Prioritize Safety in Peptide Review Camurus NDA Resubmission for CAM2029 Accepted by FDA CU Anschutz Study Raises GLP-1 Compounding Concerns IDEAYA Showcases Darovasertib Data at ESMO 2026 4DMT Reports Positive 2-Year PRISM Phase 2b Data for 4D-150 BRIJ Medical Launches BRIJ-SEAL Advanced Wound Sealant CoRegen Wins FDA IND Clearance for CRG-150 Compass to Present Tovecimig Data at ESMO 2026 Allergan Aesthetics Wins EU Approval for Boey Neurotoxin Ananda Pharma Doses First Patient in Phase 2 CIPN Trial Telix Completes Phase 3 Enrollment for Illuccix in Japan Medifast Launches Trilivy Metabolic Health System FarmaMondo Partners with Cordex to Expand Zemcelpro Inflammasome Reports Positive Phase 2 K8 Results Dimerix Secures Funding to Advance DMX-200 Phase 3 Trial Agenus Showcases BOT+BAL Data Across Three ESMO 2026 Studies Xencor Shares Kidney Cancer Trial Results at ESMO Aqemia Broadens AI Drug Discovery Research with Sanofi FDA Grants EUA for Ivermectin to Prevent Horse Screwworm HERVolution Reports HERV-K Findings in Obesity Research UF Health Lung Transplant Program Earns Top Patient Outcomes